In an unprecedented leap in scientific discovery, a new lifeform has been constructed using a mere 57 genetic instructions.

Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

The global prostate cancer diagnostics market is expected to grow at a CAGR of ~12% during the forecast period. Rising ...

Key growth drivers in the genome editing market include rising cancer/genetic disorder cases, increased investments, and ...

Scientists from the Helmholtz Institute for RNA-based Infection Research and collaborating institutions have developed a ...

First European launch of EKTERLY expected in Germany Q4 2025EKTERLY now approved in the US, EU, UK and Switzerland with additional regulatory applications under review in key global marketsFRAMINGHAM, ...

King Faisal Specialist Hospital and Research Centre (KFSHRC) has undergone remarkable developments, positioning itself among ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.

Discover the latest on Arbutus Biopharma’s patent litigation strategy and investment risks. Learn if ABUS is a speculative ...

CPT codes for OGM are key components for obtaining reimbursement from third party payers when labs use LDTs based on OGM as alternatives to legacy cytogenetics methods such as karyotyping, ...

With 1.5m Britons now using injections to lose weight and a further NHS rollout on the cards, we must consider their ...

Xenotransplantation, leveraging genetic engineering and CRISPR, offers a promising solution to the organ shortage crisis ...